Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FJ3P
|
||||
Former ID |
DIB008409
|
||||
Drug Name |
GW-2592X
|
||||
Synonyms |
Azepanone inhibitors, GlaxoSmithKline; Cathepsin K inhibitors (bone disorder); Cathepsin K inhibitors, SmithKline Beecham; GW-2592X; GW-2637X; GW-2934X; GW-9696X; SB-237632; SB-244875; SB-267320; SB-271194; SB-327537; SB-331750; SB-357114; SB-432238; SB-553484; Cathepsin K inhibitors (bone disorder), GlaxoSmithKline
|
||||
Indication | Bone disease [ICD10:M00-M99] | Investigative | [543600] | ||
Company |
SmithKline Beecham Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CC(C)([C@@H](Cc1[nH]c(cn1)c1ccc(C(F)(F)F)cc1)OC(=O)N[C@<br />H](C(=O)C(=O)Nc1[nH]ncc1)CCCC)C
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | Inhibitor | [543600] | |
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.